# Contraria Biotech: Research, Siena, Italy

> Contraria Biotech: Contraria Biotech (formerly AchilleS Vaccines) is a biopharmaceutical development company that aims to create sustainable therapeutic and...

Source: https://millionrounds.com/startup/contraria-biotech (Millionrounds; every figure on the page links to its filing or article)

Italy · [Research startup](https://millionrounds.com/companies)

# Contraria Biotech

Contraria Biotech (formerly AchilleS Vaccines) is a biopharmaceutical development company that aims to create sustainable therapeutic and prophylactic drugs against infectious diseases.

Email

Funding reported Last round: Seed

Research Siena, Italy

Follow Contraria Biotech and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fcontraria-biotech)

Company summary

- **Founded:** 2017 9 years old
- **Team:** 12 11 to 50 people
- **Funding reported:** 11.9M as listed, currency not stated
- **Last round:** Seed Jun 2020

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Contraria Biotech has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Contraria Biotech

Contraria Biotech (formerly AchilleS Vaccines) is a biopharmaceutical development company that aims to create sustainable therapeutic and prophylactic drugs against infectious diseases.

We are committed to designing innovative, cost-effective therapeutic and prophylactic products to address some of today's major global health problems, including antibiotic resistance, emerging diseases and pandemics.

## What company datasets say Contraria Biotech raised

Funding, as reported

Reported in all **11.9M** in the source's currency

Last round **Seed**

Last round size **11.9M**

Last round date **Jun 2020**

## The company, in detail

What they build

Known for

biotechnology research

Built with from their website

Aruba Microsoft Exchange Online Apple Business Manager Microsoft Exchange Microsoft 365 Outlook Microsoft 365 Apps & Services Microsoft Email Providers Aruba DNS Apple School Manager

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414, SIC 8731, 2836
- **Region:** Toscana

## Research in Italy

Startups like it

- [**Genespire** Milan · founded 2020](https://millionrounds.com/startup/genespire)
- [**Aptadir Therapeutics** Milano](https://millionrounds.com/startup/aptadir-therapeutics)
- [**Resalis Therapeutics** Turin · founded 2021](https://millionrounds.com/startup/resalis-therapeutics)
- [**Sibylla Biotech** Bresso · founded 2017](https://millionrounds.com/startup/sibylla-biotech)
- [**Algorithmiq** Milano · founded 2020](https://millionrounds.com/startup/algorithmiq)
- [**Phononic Vibes** Milan · founded 2018](https://millionrounds.com/startup/phononic-vibes-2)
- [**Cellply** Bologna · founded 2013](https://millionrounds.com/startup/cellply)
- [**Altheia Science** Milan · founded 2017](https://millionrounds.com/startup/altheia-science)

## Is this your company?

Add your raise, your deck and your story, and put Contraria Biotech in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)